APA (7th ed.) Citation

Sanaa Ahmed, Mahmoud M. El-Sayed, Mohamed A. Kandeil, & Marwa M. Khalaf. (2022). Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of α-synuclein and Parkin levels in rotenone-induced Parkinson's disease in rats. Elsevier.

Chicago Style (17th ed.) Citation

Sanaa Ahmed, Mahmoud M. El-Sayed, Mohamed A. Kandeil, and Marwa M. Khalaf. Empagliflozin Attenuates Neurodegeneration Through Antioxidant, Anti-inflammatory, and Modulation of α-synuclein and Parkin Levels in Rotenone-induced Parkinson's Disease in Rats. Elsevier, 2022.

MLA (9th ed.) Citation

Sanaa Ahmed, et al. Empagliflozin Attenuates Neurodegeneration Through Antioxidant, Anti-inflammatory, and Modulation of α-synuclein and Parkin Levels in Rotenone-induced Parkinson's Disease in Rats. Elsevier, 2022.